These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17348454)

  • 21. A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01).
    Riccardi A; Pugliese P; Danova M; Brugnatelli S; Grasso D; Giordano M; Bernardo G; Giardina G; Fava S; Montanari G; Pedrotti C; Trotti G; Rinaldi E; Poli MA; Tinelli C
    Br J Cancer; 2001 Jul; 85(2):141-6. PubMed ID: 11461067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paclitaxel in combination with weekly 24-hour infusional 5-fluorouracil plus leucovorin in the second-line treatment of metastatic breast cancer: results of a phase II study.
    Klaassen U; Wilke H; Harstrick A; Philippou Pari C; Strumberg D; Neumann K; Eberhardt W; Achterrath W; Lenaz L; Seeber S
    Ann Oncol; 1998 Jan; 9(1):45-50. PubMed ID: 9541682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of metastatic breast cancer by navelbine, mitoxantrone and continuous infusion 5-fluorouracil (FMN regimen): results of a pilot study.
    Azim HA
    J Infus Chemother; 1996; 6(2):102-6. PubMed ID: 8809659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methotrexate, mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer patients.
    Merlini L; Secondo V; Mammoliti S; Bellotti P; Castello C; Gallo L
    Anticancer Res; 1994; 14(3B):1423-6. PubMed ID: 8067717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UFT/leucovorin plus weekly paclitaxel in the treatment of solid tumors.
    Bokemeyer C; Hartmann JT; Mayer F; Böhlke I; Kanz L; Von Pawel J; Derigs G; Schröder M
    Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):63-7. PubMed ID: 11098497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High response rate with a lower dose of paclitaxel in combination with cisplatin in heavily pretreated patients with advanced breast carcinoma.
    Maiche AG; Jekunen AP; Kaleva-Kerola J; Blanco Sequeiros G
    Cancer; 2000 Apr; 88(8):1863-8. PubMed ID: 10760763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase I study. UFT/leucovorin combined with paclitaxel for anthracycline-pretreated advanced breast cancer.
    Scholz U; Lück HJ; Canzler U; Robner D; Kühnle H
    Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):44-6. PubMed ID: 11098492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levo folinic acid and 5-fluorouracil plus high dose epidoxorubicin as first line treatment for metastatic breast carcinoma.
    Gebbia V; Testa A; Valenza R; Cipolla C; Amato C; Latteri M; Gebbia N; Florena M
    Anticancer Res; 1993; 13(1):141-4. PubMed ID: 8386492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I trial of ifosfamide and 24-h infusional paclitaxel in pelvic malignancies: a Gynecologic Oncology Group study.
    Markman M; Spriggs D; Burger RA; Carson LF; Lentz SS; Gallion H
    Gynecol Oncol; 2001 Mar; 80(3):359-63. PubMed ID: 11263932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paclitaxel with mitoxantrone, fluorouracil, and high-dose leucovorin in the treatment of metastatic breast cancer: a phase II trial.
    Hainsworth JD; Jones SE; Mennel RG; Blum JL; Greco FA
    J Clin Oncol; 1996 May; 14(5):1611-6. PubMed ID: 8622079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infusional paclitaxel and weekly vinorelbine chemotherapy with concurrent filgrastim for metastatic breast cancer: high complete response rate in a phase I-II study of doxorubicin-treated patients.
    Ellis GK; Gralow JR; Pierce HI; Williams MA; Livingston RB
    J Clin Oncol; 1999 May; 17(5):1407-12. PubMed ID: 10334525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase I study of paclitaxel, UFT, and leucovorin.
    Gojo I; Tkaczuk KH
    Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):76-8. PubMed ID: 11098500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastatic breast cancer: treatment with fluorouracil-based combinations.
    Klaassen U; Seeber S
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):69-73. PubMed ID: 9348573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paclitaxel and UFT plus oral calcium folinate in pretreated metastatic breast cancer.
    Klaassen U; Borquez D; Lang S; Oberhoff C; Harstrick A; Seeber S; Benner S
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):71-3. PubMed ID: 10442367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary results of a phase II trial for the treatment of metastatic breast cancer with 5-fluorouracil and leucovorin.
    Allegra CJ; Chabner BA; Sholar PW; Bagley C; Drake JC; Lippman ME
    NCI Monogr; 1987; (5):199-202. PubMed ID: 3501543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UFT/oral calcium folinate plus weekly paclitaxel for metastatic breast cancer.
    Lück HJ; Scholz U; Kühnle H; Dethling J
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):74-6. PubMed ID: 10442368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of previously treated metastatic breast cancer by mitoxantrone and 48-hour continuous infusion of high-dose 5-FU and leucovorin (MFL): low palliative benefit and high treatment-related toxicity.
    Yen CC; Tung SL; Hsieh RK; Chiou TJ; Liu JH; Wang WS; Chen PM
    Jpn J Clin Oncol; 1997 Oct; 27(5):316-20. PubMed ID: 9390208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymic carcinoma with autoimmune syndrome: successful treatment with weekly infusional high-dose 5-fluorouracil and leucovorin.
    Hsu CH; Yeh KH; Cheng AL
    Anticancer Res; 1997; 17(2B):1331-4. PubMed ID: 9137493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preliminary results. UFT/methotrexate/leucovorin for breast Ca patients in progression after HDCT/PBPC support.
    Martin M; Casado A; López-Martin JA; Rodriguez-Lescure A; Nieto Y; Ayala F; Diaz-Rubio E
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):83-5. PubMed ID: 9348575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II study of weekly mitoxantrone, 5-fluorouracil, and leucovorin in metastatic breast cancer.
    Repetto L; Miglietta L; Gardin G; Lanfranco C; Naso C; Merlini L; Giudici S; Venturino A; Campora E; Testore F
    Breast Cancer Res Treat; 1994; 30(2):133-7. PubMed ID: 7949211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.